Innovation
17 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,125 times.
| Year | Filings |
|---|---|
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 10 |
| 2017 | 7 |
| 2018 | 8 |
| 2019 | 7 |
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Social engagement
Social engagement: 2.4K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
3 investors on record; lead investors include REPAIR Impact Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Other / undisclosed | 2 | 67% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
1 Jul 2026 · Scientist III – Immunology & Flow Cytometry · Rockville, MD
Based on job postings tracked across public sources.
Recent activity
20 May 2026
Product launch
recombinant WEEV E3E2 Protein (His-Tag)